White House Press Secretary Karoline Leavitt has called on ABC News to retract a report alleging the FBI warned of a potential Iranian drone attack on California, accusing the network of misleading the public with unverified information.
For the first time in 20 years, Australian Broadcasting Corporation staff have walked off the job in a 24-hour strike, disrupting live news and forcing the broadcaster to air BBC content. The industrial action follows a breakdown in negotiations over a pay offer unions deem insufficient against rising inflation.
At the TD Cowen Healthcare Conference, Alector detailed significant progress on its proprietary ABC platform designed to ferry therapies across the blood-brain barrier. Key programs AL137 for Alzheimer's and AL050 for Parkinson's showed robust preclinical data, with IND filings on the horizon.
Abcourt Mines initiates a significant second-phase drilling campaign at its Flordin Property in Quebec, aiming to expand and connect high-grade gold zones over a two-kilometer corridor near established mining infrastructure.
Once a high-flying AI discovery platform, AbCellera Biologics is navigating a critical transition to a clinical-stage biotech. With a fortified balance sheet and key Phase 1 readouts on the horizon, some investors see a compelling, albeit risky, turnaround story taking shape.
Press Secretary Karoline Leavitt has called on ABC News to withdraw a story detailing an unverified FBI alert about potential Iranian drone strikes on the West Coast, labeling the reporting as misleading and alarmist.
Despite posting an annual net loss, the antibody discovery leader points to strategic progress in its oncology and immunology programs, with key Phase 1 data readouts anticipated this year.
Shares of antibody discovery firm AbCellera Biologics (ABCL) present a complex picture for investors, with strong one-year gains overshadowed by steep declines over longer horizons. As the stock trades near $3.86, a significant gap emerges between its market price and some analyst fair value estimates, raising questions about its premium valuation in a challenging biotech market.
Shares of antibody discovery firm AbCellera Biologics plunged 16.8% last week, reigniting debate over its true worth. While a discounted cash flow model suggests deep undervaluation, its sky-high price-to-sales ratio paints a starkly different picture, leaving investors to navigate conflicting signals in a volatile biotech market.
The international professional services association strengthens its network in key markets by welcoming ABConzult in Montevideo and Elaion Tax in the United States.
AbCellera Biologics sees its stock climb over 11% following its latest financial report, which showed improved revenue and a reduced net loss. The company also filed to register additional shares for its employee stock plan, signaling a focus on long-term talent retention amid critical clinical milestones.
Amid a volatile market and a surprising exit from Nvidia, SoftBank Group is placing strategic new wagers on fintech, biotech, and crypto infrastructure firms for the coming year.
Bahrain's Bank ABC has completed a critical first phase in its group-wide digital transformation, moving its fully digital ila Bank onto the Temenos core platform hosted on AWS, with plans to consolidate systems across 15 countries.
The U.S. biogas sector added just 70 new facilities in 2025, marking the slowest growth since 2019. While long-term expansion remains strong, industry leaders point to regulatory shifts and a search for new demand drivers beyond transportation fuels as key factors in the slowdown.
AbCellera Biologics reports robust fourth-quarter financial performance for 2025, driven by partnership milestones, while detailing its strategic push into new therapeutic areas and platform enhancements.
While construction job openings rose to a five-month high at the end of 2025, hiring over the past two years remains at its lowest level in nearly a decade, according to industry economists. Experts point to a complex mix of material costs, immigration policy, and cautious demand tempering the sector's recovery.
Shares of Ameris Bancorp (ABCB) have surged over 25% in six months, significantly outpacing the broader market. While the momentum is undeniable, a closer look at key financial metrics suggests caution may be warranted for investors considering new positions.
In a contentious exchange on ABC's "This Week," Representative Mike Turner (R-OH) repeatedly deflected host George Stephanopoulos's pointed questions about whether U.S. ground troops would be necessary to secure the Strait of Hormuz, pivoting instead to broader warnings about Iran's nuclear ambitions.
Secretary of State Marco Rubio faced pointed questioning from ABC's George Stephanopoulos over the administration's seemingly conflicting stances on Iran—branding its leaders 'insane' while simultaneously claiming backchannel negotiations with a 'more reasonable' emerging power structure.
Mounting regional strikes by Iran pressure neighboring nations to reassess their stance in the widening conflict, while bipartisan urgency grows to end the Homeland Security shutdown. Separately, cast members of a Hulu series voice serious concerns to executives about a fellow star's legal troubles.
